Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Sclerosis | 21 | 2024 | 3224 | 2.820 |
Why?
|
Epstein-Barr Virus Infections | 5 | 2024 | 612 | 1.440 |
Why?
|
Herpesvirus 4, Human | 5 | 2024 | 1079 | 0.950 |
Why?
|
Norway | 10 | 2023 | 498 | 0.860 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 2 | 2020 | 556 | 0.850 |
Why?
|
Registries | 6 | 2023 | 8223 | 0.820 |
Why?
|
Minerals | 1 | 2019 | 283 | 0.580 |
Why?
|
Cod Liver Oil | 1 | 2015 | 9 | 0.510 |
Why?
|
Cesarean Section | 1 | 2023 | 1396 | 0.480 |
Why?
|
Parkinson Disease | 4 | 2024 | 2877 | 0.470 |
Why?
|
Body Size | 1 | 2017 | 463 | 0.460 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 1 | 2016 | 254 | 0.450 |
Why?
|
Sodium, Dietary | 1 | 2017 | 425 | 0.450 |
Why?
|
Physical Fitness | 1 | 2017 | 739 | 0.410 |
Why?
|
Premature Birth | 2 | 2021 | 1782 | 0.400 |
Why?
|
Uric Acid | 1 | 2018 | 807 | 0.390 |
Why?
|
Smoking | 4 | 2023 | 9052 | 0.360 |
Why?
|
Cholecalciferol | 1 | 2015 | 553 | 0.350 |
Why?
|
Menopause | 1 | 2018 | 1646 | 0.340 |
Why?
|
Neurofilament Proteins | 3 | 2022 | 336 | 0.330 |
Why?
|
Vitamin D | 3 | 2020 | 3301 | 0.330 |
Why?
|
Demyelinating Diseases | 2 | 2022 | 351 | 0.310 |
Why?
|
Diet | 5 | 2024 | 8074 | 0.310 |
Why?
|
Sex Characteristics | 1 | 2018 | 2637 | 0.290 |
Why?
|
Case-Control Studies | 12 | 2024 | 22168 | 0.280 |
Why?
|
Exercise | 3 | 2021 | 5884 | 0.280 |
Why?
|
Amyotrophic Lateral Sclerosis | 3 | 2023 | 1469 | 0.270 |
Why?
|
Risk | 5 | 2019 | 9612 | 0.260 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2021 | 3704 | 0.260 |
Why?
|
Cotinine | 3 | 2023 | 206 | 0.260 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 2 | 2024 | 157 | 0.260 |
Why?
|
Infectious Mononucleosis | 2 | 2016 | 133 | 0.250 |
Why?
|
Body Mass Index | 3 | 2022 | 12951 | 0.230 |
Why?
|
Antibodies, Viral | 4 | 2024 | 3155 | 0.220 |
Why?
|
Prospective Studies | 11 | 2024 | 54415 | 0.220 |
Why?
|
Cognition | 1 | 2020 | 6986 | 0.200 |
Why?
|
Dietary Supplements | 1 | 2015 | 3414 | 0.200 |
Why?
|
Cohort Studies | 12 | 2023 | 41446 | 0.190 |
Why?
|
Flavonoids | 1 | 2024 | 445 | 0.180 |
Why?
|
Young Adult | 11 | 2024 | 59207 | 0.180 |
Why?
|
Military Personnel | 3 | 2024 | 1246 | 0.170 |
Why?
|
Preconception Care | 1 | 2021 | 141 | 0.170 |
Why?
|
Phosphorus, Dietary | 1 | 2019 | 20 | 0.170 |
Why?
|
Potassium, Dietary | 1 | 2019 | 103 | 0.160 |
Why?
|
Intuition | 1 | 2018 | 20 | 0.160 |
Why?
|
Infant, Small for Gestational Age | 1 | 2021 | 461 | 0.160 |
Why?
|
Female | 27 | 2024 | 392581 | 0.160 |
Why?
|
Adult | 20 | 2024 | 221148 | 0.160 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2022 | 294 | 0.160 |
Why?
|
Time | 1 | 2020 | 545 | 0.150 |
Why?
|
Iron, Dietary | 1 | 2019 | 148 | 0.150 |
Why?
|
Humans | 38 | 2024 | 761423 | 0.150 |
Why?
|
Validation Studies as Topic | 1 | 2017 | 162 | 0.140 |
Why?
|
Infant Mortality | 1 | 2021 | 759 | 0.140 |
Why?
|
Risk Factors | 15 | 2024 | 74167 | 0.130 |
Why?
|
Copper | 1 | 2019 | 369 | 0.130 |
Why?
|
Celiac Disease | 1 | 2024 | 825 | 0.130 |
Why?
|
Gout Suppressants | 1 | 2018 | 177 | 0.130 |
Why?
|
Birth Weight | 2 | 2021 | 2100 | 0.130 |
Why?
|
Manganese | 1 | 2019 | 395 | 0.130 |
Why?
|
Calcium, Dietary | 1 | 2019 | 529 | 0.130 |
Why?
|
Epidemiology | 1 | 2018 | 279 | 0.130 |
Why?
|
Pregnancy | 6 | 2023 | 29862 | 0.130 |
Why?
|
Science | 1 | 2018 | 239 | 0.130 |
Why?
|
Middle Aged | 16 | 2024 | 220826 | 0.130 |
Why?
|
Child of Impaired Parents | 1 | 2019 | 460 | 0.130 |
Why?
|
Gestational Age | 2 | 2021 | 3576 | 0.130 |
Why?
|
Adolescent | 9 | 2022 | 88313 | 0.130 |
Why?
|
Magnesium | 1 | 2019 | 808 | 0.130 |
Why?
|
Vaccines | 1 | 2023 | 837 | 0.120 |
Why?
|
Zinc | 1 | 2019 | 690 | 0.120 |
Why?
|
Early Diagnosis | 1 | 2020 | 1186 | 0.120 |
Why?
|
Adjuvants, Immunologic | 1 | 2020 | 1036 | 0.120 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2023 | 1390 | 0.110 |
Why?
|
Disability Evaluation | 1 | 2021 | 1836 | 0.110 |
Why?
|
Male | 20 | 2024 | 360736 | 0.110 |
Why?
|
Child Abuse | 1 | 2022 | 1075 | 0.110 |
Why?
|
Breast Feeding | 1 | 2021 | 1358 | 0.100 |
Why?
|
Infant, Newborn | 2 | 2023 | 26212 | 0.100 |
Why?
|
Mothers | 2 | 2021 | 2192 | 0.100 |
Why?
|
Peptides | 1 | 2024 | 4345 | 0.100 |
Why?
|
Databases, Factual | 2 | 2018 | 7956 | 0.100 |
Why?
|
Nurses | 2 | 2021 | 2478 | 0.100 |
Why?
|
Ritonavir | 1 | 2013 | 329 | 0.090 |
Why?
|
HIV Protease Inhibitors | 1 | 2013 | 432 | 0.090 |
Why?
|
Aged | 9 | 2024 | 169235 | 0.080 |
Why?
|
Age Factors | 2 | 2018 | 18400 | 0.080 |
Why?
|
Dementia | 1 | 2024 | 2686 | 0.080 |
Why?
|
Follow-Up Studies | 3 | 2020 | 39117 | 0.080 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 3204 | 0.080 |
Why?
|
Longitudinal Studies | 2 | 2022 | 14599 | 0.070 |
Why?
|
Proportional Hazards Models | 2 | 2024 | 12456 | 0.070 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2021 | 3441 | 0.070 |
Why?
|
Mental Health | 1 | 2021 | 3249 | 0.070 |
Why?
|
Social Class | 1 | 2015 | 2004 | 0.070 |
Why?
|
Cytomegalovirus | 2 | 2022 | 756 | 0.070 |
Why?
|
Double-Blind Method | 1 | 2020 | 12330 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2015 | 10766 | 0.060 |
Why?
|
Migraine Disorders | 1 | 2017 | 1700 | 0.060 |
Why?
|
Adrenal Cortex Hormones | 2 | 2023 | 1876 | 0.060 |
Why?
|
Incidence | 2 | 2019 | 21341 | 0.060 |
Why?
|
Pesticide Residues | 1 | 2024 | 95 | 0.050 |
Why?
|
Infant | 2 | 2021 | 36205 | 0.050 |
Why?
|
Cholinergic Antagonists | 1 | 2023 | 168 | 0.050 |
Why?
|
Aging | 1 | 2021 | 8705 | 0.050 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2023 | 225 | 0.050 |
Why?
|
Asthma | 1 | 2019 | 6211 | 0.040 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2023 | 540 | 0.040 |
Why?
|
Quality of Life | 1 | 2021 | 13361 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2017 | 5840 | 0.040 |
Why?
|
HLA Antigens | 1 | 2024 | 1371 | 0.040 |
Why?
|
Fruit | 1 | 2024 | 1160 | 0.040 |
Why?
|
Vegetables | 1 | 2024 | 1196 | 0.040 |
Why?
|
Maternal Age | 1 | 2021 | 809 | 0.040 |
Why?
|
Finland | 1 | 2019 | 607 | 0.040 |
Why?
|
Diet, Mediterranean | 1 | 2024 | 740 | 0.040 |
Why?
|
United States | 3 | 2024 | 72339 | 0.030 |
Why?
|
Disease Progression | 2 | 2023 | 13502 | 0.030 |
Why?
|
Diet Surveys | 1 | 2019 | 1162 | 0.030 |
Why?
|
Brazil | 1 | 2019 | 1230 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2018 | 58956 | 0.030 |
Why?
|
Fatty Acids | 1 | 2023 | 1808 | 0.030 |
Why?
|
Italy | 1 | 2017 | 843 | 0.030 |
Why?
|
Age of Onset | 1 | 2022 | 3304 | 0.030 |
Why?
|
Food | 1 | 2019 | 772 | 0.030 |
Why?
|
Reference Values | 1 | 2021 | 4921 | 0.030 |
Why?
|
Logistic Models | 2 | 2020 | 13255 | 0.030 |
Why?
|
Nontherapeutic Human Experimentation | 1 | 2013 | 22 | 0.030 |
Why?
|
Sweden | 1 | 2017 | 1379 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3580 | 0.030 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2013 | 114 | 0.030 |
Why?
|
Women's Health | 1 | 2021 | 2065 | 0.020 |
Why?
|
Midazolam | 1 | 2013 | 266 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2024 | 4764 | 0.020 |
Why?
|
Europe | 1 | 2016 | 3423 | 0.020 |
Why?
|
Lipids | 1 | 2020 | 3340 | 0.020 |
Why?
|
Recurrence | 1 | 2022 | 8469 | 0.020 |
Why?
|
Area Under Curve | 1 | 2013 | 1638 | 0.020 |
Why?
|
Child | 3 | 2022 | 80162 | 0.020 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2021 | 2509 | 0.020 |
Why?
|
Educational Status | 1 | 2015 | 2520 | 0.020 |
Why?
|
Pregnancy Complications | 1 | 2021 | 2947 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2019 | 4549 | 0.020 |
Why?
|
Prevalence | 1 | 2022 | 15717 | 0.010 |
Why?
|
Odds Ratio | 1 | 2016 | 9645 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 26112 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 12938 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2021 | 12143 | 0.010 |
Why?
|
Risk Assessment | 1 | 2016 | 23990 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2022 | 36423 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2021 | 80582 | 0.010 |
Why?
|
Concepts
(151)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(23)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_